Marco Rabusin

2.3k total citations
43 papers, 818 citations indexed

About

Marco Rabusin is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marco Rabusin has authored 43 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 16 papers in Hematology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marco Rabusin's work include Acute Lymphoblastic Leukemia research (18 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Marco Rabusin is often cited by papers focused on Acute Lymphoblastic Leukemia research (18 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Marco Rabusin collaborates with scholars based in Italy, United States and Switzerland. Marco Rabusin's co-authors include Jakob Passweg, Giuliana Decorti, Gabriele Stocco, Raffaella Franca, Franco Locatelli, Franca Fagioli, C J Hawkey, Sandro Ardizzone, Edoardo Lanino and Gianluigi Mancardi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Marco Rabusin

36 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Rabusin Italy 15 359 213 195 168 133 43 818
Alexey Maschan Russia 17 477 1.3× 211 1.0× 231 1.2× 80 0.5× 147 1.1× 137 854
Man Updesh Singh Sachdeva India 13 245 0.7× 141 0.7× 126 0.6× 94 0.6× 107 0.8× 118 648
W.-D. Ludwig Germany 17 449 1.3× 319 1.5× 134 0.7× 84 0.5× 204 1.5× 37 754
Pascale Schneider France 14 252 0.7× 169 0.8× 119 0.6× 203 1.2× 394 3.0× 58 921
Thomas Kiss Canada 19 756 2.1× 168 0.8× 264 1.4× 134 0.8× 133 1.0× 76 1.3k
Dolors Costa Spain 21 400 1.1× 121 0.6× 126 0.6× 280 1.7× 299 2.2× 73 1.2k
J. P. Jouet France 18 807 2.2× 194 0.9× 257 1.3× 88 0.5× 127 1.0× 34 1.1k
Hisaya Nakadate Japan 21 199 0.6× 259 1.2× 83 0.4× 82 0.5× 341 2.6× 65 919
Vaneuza Araújo Moreira Funke Brazil 14 431 1.2× 111 0.5× 108 0.6× 44 0.3× 120 0.9× 61 646
Hyery Kim South Korea 16 198 0.6× 148 0.7× 83 0.4× 69 0.4× 110 0.8× 100 665

Countries citing papers authored by Marco Rabusin

Since Specialization
Citations

This map shows the geographic impact of Marco Rabusin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Rabusin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Rabusin more than expected).

Fields of papers citing papers by Marco Rabusin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Rabusin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Rabusin. The network helps show where Marco Rabusin may publish in the future.

Co-authorship network of co-authors of Marco Rabusin

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Rabusin. A scholar is included among the top collaborators of Marco Rabusin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Rabusin. Marco Rabusin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
4.
Pastore, Serena, Erica Valencic, Alberto Tommasini, et al.. (2019). Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature. Pediatric Drugs. 21(3). 185–193. 35 indexed citations
5.
Franca, Raffaella, Gabriele Stocco, Franco Locatelli, et al.. (2019). PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients. The Pharmacogenomics Journal. 20(3). 415–425. 16 indexed citations
6.
Zecca, Marco, Chiara Messina, Elisa Carraro, et al.. (2018). Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children. Bone Marrow Transplantation. 54(2). 275–283. 9 indexed citations
7.
Stocco, Gabriele, Raffaella Franca, Alessandro Ventura, et al.. (2017). PACSIN2 rs2413739 Polymorphism and Thiopurine Pharmacokinetics: Validation Studies in Pediatric Patients. Blood. 130. 4999–4999. 1 indexed citations
8.
Lega, Sara, Marco Rabusin, & Federica Pederiva. (2014). Acute-onset pretibial swelling. Indian Pediatrics. 51(4). 334–334. 2 indexed citations
9.
Franca, Raffaella, Paola Rebora, Emmanouil Athanasakis, et al.. (2014). TNF- α SNP rs1800629 and Risk of Relapse in Childhood Acute Lymphoblastic Leukemia: Relation to Immunophenotype. Pharmacogenomics. 15(5). 619–627. 1 indexed citations
10.
Stocco, Gabriele, et al.. (2013). Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia. Frontiers in Genetics. 3. 309–309. 16 indexed citations
11.
Anzini, Marco, et al.. (2013). Abrupt Intracardiac Growth of a Wilms Tumor. The Journal of Pediatrics. 163(3). 918–918.e1. 1 indexed citations
12.
Sieni, Elena, Valentina Cetica, Andrea Piccin, et al.. (2012). Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series. PLoS ONE. 7(9). e44649–e44649. 61 indexed citations
13.
Stocco, Gabriele, Wenjian Yang, Kristine R. Crews, et al.. (2012). PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Human Molecular Genetics. 21(21). 4793–4804. 52 indexed citations
15.
Snowden, John A., Riccardo Saccardi, Matthieu Allez, et al.. (2011). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 47(6). 770–790. 218 indexed citations
17.
Passweg, Jakob & Marco Rabusin. (2008). Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias. Autoimmunity. 41(8). 660–665. 22 indexed citations
18.
Rabusin, Marco, et al.. (2008). Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives. Bone Marrow Transplantation. 41(S2). S96–S99. 16 indexed citations
19.
Busca, Alessandro, Edoardo Lanino, Luca Manfredini, et al.. (2000). Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplantation. 25(10). 1067–1071. 45 indexed citations
20.
Colombo, A., Emilio Paolo Alessandrino, Paolo Bernasconi, et al.. (1999). N-ACETYLCYSTEINE IN THE TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST-DISEASE. Transplantation. 68(9). 1414–1416. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026